This is at least the fourth claim I have read on accurate blood-based biomarker testing for AD, each claiming to be the first, with the CSIRO being among them with Prana biotech having some skin in the game as well.
It's all good, but determining who goT there first is going to be a challenge for sure.
- Forums
- ASX - By Stock
- potential blood test early alzheimers
This is at least the fourth claim I have read on accurate...
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.937K | 645.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
77 | 96988980 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 655773 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
77 | 96988980 | 0.002 |
26 | 136640147 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 655773 | 2 |
0.004 | 152387339 | 56 |
0.005 | 8366584 | 12 |
0.006 | 16581534 | 13 |
0.007 | 53884874 | 26 |
Last trade - 10.00am 15/11/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online